Prof. Chengzhi Lv | Psoriais Treatment | Best Researcher Award

Posted on 16/09/202526/09/2025 by Skincare

Prof. Chengzhi Lv | Psoriais Treatment | Best Researcher Award

Professor | Dalian Dermatosis Hospital | China

Dr. Chengzhi Lv, Director of Dalian Dermatosis Hospital, is a distinguished researcher and clinician specializing in inflammatory skin diseases. He has developed a cross-disciplinary research framework to uncover the molecular mechanisms linking skin barrier homeostasis and systemic inflammatory factors, including IL-1β, IL-6, and TNF-α. Dr. Lv holds a robust academic background with numerous completed and ongoing research projects funded by prestigious institutions such as the National Natural Science Foundation of China, the Chinese Academy of Medical Sciences, and the Guangdong Provincial Department of Science and Technology. His work spans advanced studies on psoriasis, vitiligo, melanoma, and autoimmune diseases, as well as the development of emollients and novel therapeutic approaches integrating traditional Chinese and Western medicine. He has authored several books, including Chinese and Western Medicine Dermatology and Venereology and Psoriasis Diagnosis and Treatment Manual, and published widely in high-impact journals such as Frontiers in Immunology and the Journal of the European Academy of Dermatology and Venereology. His contributions include pioneering the “Dalian Model” for comprehensive psoriasis management, which significantly reduces recurrence rates. Dr. Lv is also a patent holder for innovative dermatological treatments and serves as Editor-in-Chief of both the Chinese Journal of Integrated Traditional Chinese and Western Medicine in Dermatology and Venereology and the Journal of Practical Dermatology. Recognized nationally for his leadership in clinical dermatology, Dr. Lv continues to advance the integration of clinical care, research, and innovation to improve outcomes for patients with chronic skin disorders. He has 521 citations from 464 documents with an h-index of 12.

Profile: Scopus

Publications

1. Panpan Liu; Yehong Kuang; Li Ye; Cong Peng; Wangqing Chen; Minxue Shen; Mi Zhang; Wu Zhu;Chengzhi Lv; Xiang Chen ; Predicting the risk of psoriatic arthritis in plaque psoriasis patients: development and assessment of a new predictive nomogram, Frontiers in Immunology, 2022, 12；

2. L Ye; Z Wang; Y Kim; PM Elias; T Li; S Wen; J Song; C Lv; B Yang; MQ Man ; A Topical Emollient Mitigates the Progression of Cognitive Impairment in the Elderly: A Randomized, Open‐ Label Pilot Trial, Journal of the European Academy of Dermatology and Venereology, 2022, 36(8): 1382-1388；

3. Yehong Kuang; Yi Xiao; Zhiqin Fang; Yichi Zhang; Minxue Shen; Xiang Chen; Mingliang Chen; Chengzhi Lv; Wu Zhu ; Association of serum vitamin D with psoriasis and effect modification by central obesity., Front Med (Lausanne), 2020, 7(236)；

4. Ye, L.; Mauro, T. M.; Dang, E.; Wang, G.; Hu, L. Z.; Yu, C.; Jeong, S.; Feingold, K.; Elias, P. M.; Lv, C. Z.; Man, M. Q. ; Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study, Journal of the European Academy of Dermatology and Venereology, 2019, 33(11): 2197-2201；

5. Ye, L; Wang, Z; Li, Z; Lv, C; Man, M Q ; Validation of GPSkin Barrier((R)) for assessing epidermal permeability barrier function and stratum corneum hydration in humans, Skin Research and Technology, 2018, 25(1): 25-29

Hui Xiong | Pharmaceutics | Best Researcher Award

Posted on 28/08/202527/09/2025 by Skincare

Dr. Hui Xiong is an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University, where she leads pioneering research in advanced drug delivery systems and nanomedicine engineering. She earned her Ph.D. in Pharmaceutics and has since focused her career on the rational design of multifunctional nanocarriers to improve the bioavailability, targeting precision, and therapeutic index of anticancer drugs. Her work integrates pharmaceutics, tumor biology, and materials science to develop innovative delivery platforms for combination therapy, pH-activated antiangiogenic chemotherapy, tumor microenvironment modulation, and ferroptosis-inducing therapeutic strategies, with a strong emphasis on breast and pancreatic cancer treatment. Dr. Xiong has published over 30 SCI papers as first or corresponding author in leading journals such as ACS Nano, Nano Letters, Journal of Controlled Release, Small, and Advanced Healthcare Materials, accumulating a total impact factor exceeding 188 and an H-index of 16. Her contributions include groundbreaking studies on vascular normalization, metabolic symbiosis-blocking nanocombinations, bioengineered nanospores for macrophage modulation, and redox-regulated nanodrugs, several of which have been featured on journal covers. She has been the principal investigator for multiple National Natural Science Foundation of China projects and holds four national invention patents, advancing translational pharmaceutics for clinical oncology. Recognized for her contributions to cancer nanomedicine, she also serves as a peer reviewer for several high-impact journals, further shaping the direction of pharmaceutics and targeted drug delivery research.

Profile : ORCID

Publications

1. He, Z., Wang, R., Qi, Y., Liu, Y., Xiong, H.*, & Yao, J. (2024). Nanocoated bacteria with H₂S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy. Journal of Controlled Release.

2. Qiao, J., Liu, S., Huang, Y., Zhu, X., Xue, C., Wang, Y., Xiong, H.*, & Yao, J. (2024). Glycolysis–noncanonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment. Journal of Colloid and Interface Science.

3. Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H.* (2024). Recent progress in anti-tumor nanodrugs based on tumor microenvironment redox regulation. Small.

4. Shang, Y., Lu, H., Liao, L., Li, S., Xiong, H.*, & Yao, J. (2023). Bioengineered nanospores selectively blocking LC3-associated phagocytosis in tumor-associated macrophages potentiate antitumor immunity. ACS Nano.

5. Xiong, H., Liu, X., Xie, Z., Zhu, L., Lu, H., Wang, C., & Yao, J. (2022). Metabolic symbiosis-blocking nanocombination for tumor vascular normalization treatment. Advanced Healthcare Materials.

Aline Batch | Antioxidants | Best Academic Researcher Award

Posted on 13/08/202511/10/2025 by Skincare

Mrs. Aline Batch | Antioxidants | Best Academic Researcher Award

PhD. Candidate | University Of Aleppo | Syria

Aline Nadim Batch is a Ph.D. candidate in Plant Taxonomy and Ecology at the University of Aleppo, where she also serves as a lecturer in the Department of Plant Biology. She holds an M.Sc. in Plant Taxonomy and Ecology and a B.Sc. in Natural Sciences (Biology), reflecting a strong academic foundation in biodiversity and ecological sciences. Her research focuses on documenting and classifying the flora of Syria, integrating traditional taxonomic methods with modern ecological approaches to advance knowledge of plant diversity. Aline has published multiple peer-reviewed papers, including a contribution to a Q1 Scopus-indexed journal, underscoring the impact of her work on the scientific community. She actively participates in ecological fieldwork and leads the innovative Digital Flora of Syria project, which digitally records and shares plant species data to support conservation and botanical education. Her consultancy projects include biodiversity inventories, habitat assessments, and contributions to sustainable land management initiatives in collaboration with environmental organizations. Aline’s dedication has earned her recognition through citations of her research, collaborations with regional academic institutions, and memberships in professional scientific societies. In addition to her research achievements, she serves as a moderator and editor for the Digital Flora of Syria, ensuring the accuracy and quality of data shared with researchers and conservationists. Fluent in Arabic, English, and French, she is committed to advancing plant science, fostering international collaborations, and promoting awareness of ecological preservation and sustainable resource management.

Profile: ORCID

Publications

1. Batch, A. (2025). Antioxidant activity of some Apiaceae plants wild distributed in Aleppo, Syria. South African Journal of Chemical Engineering.

2. Batch, A. (2025). Chemical fingerprint of some wild Apiaceae species distributed in Aleppo, Syria, based on thin-layer chromatography. Preprint.

3. Batch, A. (2024). Biodiversity of Apiaceae plants distributed in Aleppo. Aleppo University Journal of Research.

4. Batch, A. (2024, May). Botanicals for cosmetics in Syria. 18th Congress of the International Society of Ethnobiology, Marrakech, Morocco.

5. Batch, A. (2023). Taxonomic and phytochemical study of Geraniaceae species distributed in Aleppo flora. Doctoral dissertation, University of Aleppo.